Concourse Financial Group Securities’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
OAG
HL
Concourse Financial Group Securities's GMAB Position: Q1 2025 in Review
Concourse Financial Group Securities sold out of Genmab (GMAB) in Q1 2025, closing a stake of 390 shares — an estimated $8.18K sold.
Concourse Financial Group Securities first reported a position in GMAB in Q3 2019 and held it in 22 quarters. The position peaked at $20.1K in Q3 2023. 220 funds tracked by Wall St. Rank hold GMAB as of Q1 2025.
- Concourse Financial Group Securities reported no remaining Genmab position as of Q1 2025 after selling out during the quarter.
- Concourse Financial Group Securities sold 390 Genmab shares in Q1 2025, an estimated $8.18K.
- Concourse Financial Group Securities first reported a position in Genmab in Q3 2019 and held it in 22 quarters.
- Concourse Financial Group Securities's Genmab position peaked at $20.1K in Q3 2023.
- 220 funds tracked by Wall St. Rank held Genmab as of Q1 2025.
Based on Concourse Financial Group Securities's 13F filing for Q1 2025.